Evidence map›Paper›PMID 7962052›Full record

ArticleThe Journal of cell biology1994

LDLC encodes a brefeldin A-sensitive, peripheral Golgi protein required for normal Golgi function.

S D Podos, P Reddy, J Ashkenas, M Krieger

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of cell biology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Golgi glycosylation.Cold Spring Harbor perspectives in biology · 2011
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Structural basis for a human glycosylation disorder caused by mutation of the COG4 gene.Proceedings of the National Academy of Sciences of the United States of America · 2009
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

S D PodosDepartment of Biology, Massachusetts Institute of Technology, Cambridge 02139.
P Reddy
J Ashkenas
M Krieger
Massachusetts Institute of Technology · US

Funding

STUDY OF THE FIBRONECTIN FUNCTIONP01HL041484 · NHLBI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ROSENBERG, ROBERT D · 1988 to 2000
$2.7M
IMMUNOLOGICAL ANALYSIS OF LDL RECEPTOR DEFECTIVE CELLSR01HL032459 · NHLBI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI KRIEGER, MONTY · 1985 to 1992
–
NCRR NIH HHS RR05734NHLBI NIH HHS HL32459NHLBI NIH HHS HL41484
6 · The paper itself

Abstract

Two genetically distinct classes of low density lipoprotein (LDL) receptor-deficient Chinese hamster ovary cell mutants, ldlB and ldlC, exhibit nearly identical pleiotropic defects in multiple medial and trans Golgi-associated processes (Kingsley, D., K. F. Kozarsky, M. Segal, and M. Krieger. 1986. J. Cell Biol. 102:1576-1585). In these mutants, the synthesis of virtually all N- and O-linked glycoproteins and of the major lipid-linked oligosaccharides is abnormal. The abnormal glycosylation of LDL receptors in ldlB and ldlC cells results in their dramatically reduced stability and thus very low LDL receptor activity. We have cloned and sequenced a human cDNA (LDLC) which corrects the mutant phenotypes of ldlC, but not ldlB, cells. Unlike wild-type CHO or ldlB cells, ldlC cells had virtually no detectable endogenous LDLC mRNA, indicating that LDLC is likely to be the normal human homologue of the defective gene in ldlC cells. The predicted sequence of the human LDLC protein (ldlCp, approximately 83 kD) is not similar to that of any known proteins, and contains no major common structural motifs such as transmembrane domains or an ER translocation signal sequence. We have also determined the sequence of the Caenorhabditis elegans ldlCp by cDNA cloning and sequencing. Its similarity to that of human ldlCp suggests that ldlCp mediates a well-conserved cellular function. Immunofluorescence studies with anti-ldlCp antibodies in mammalian cells established that ldlCp is a peripheral Golgi protein whose association with the Golgi is brefeldin A sensitive. In ldlB cells, ldlCp was expressed at normal levels; however, it was not associated with the Golgi. Thus, a combination of somatic cell and molecular genetics has identified a previously unrecognized protein, ldlCp, which is required for multiple Golgi functions and whose peripheral association with the Golgi is both LDLB dependent and brefeldin A sensitive.

Indexed as

Caenorhabditis elegans ProteinsProtein BiosynthesisAdaptor Proteins, Vesicular TransportAmino Acid SequenceAnimalsBase SequenceBlotting, NorthernBrefeldin ACaenorhabditis elegansCHO CellsClone CellsCloning, MolecularCricetinaeCyclopentanesDNA, ComplementaryDNA PrimersAdaptor Proteins, Vesicular TransportBrefeldin ACaenorhabditis elegans ProteinsCOG2 protein, humancogc-2 protein, C elegansCyclopentanesDNA, ComplementaryDNA PrimersProteinsProtein Synthesis InhibitorsTranscription Factors

Identifiers

PMID7962052
PMCPMC2120235
OpenAlexW2154056846

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.